{
  "schema_version": "0.3",
  "id": "immunovant-inc",
  "type": "organization",
  "label": "Immunovant, Inc.",
  "aliases": [
    {
      "value": "Immunovant Sciences GmbH (Switzerland)",
      "lang": "en"
    },
    {
      "value": "Immunovant Sciences",
      "lang": "en"
    },
    {
      "value": "Immunovant Sciences LLC",
      "lang": "en"
    },
    {
      "value": "Immunovant Sciences GmbH",
      "lang": "en"
    },
    {
      "value": "IMVT",
      "lang": "en"
    }
  ],
  "description": "company in Basel, Switzerland",
  "tier": 1,
  "status": "active",
  "redirect_to": null,
  "fp_kind": null,
  "synthetic": false,
  "identifiers": {
    "wikidata": "Q140045442",
    "cik": "0001764013",
    "domain": [
      "immunovant.com"
    ]
  },
  "inbound_counts": {},
  "claims": [
    {
      "id": "k_61a2ac6881ddb4ae31a2d0a821fa8543",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "identifier",
      "object": null,
      "value": {
        "scheme": "wikidata",
        "value": "Q140045442"
      },
      "datatype": "identifier",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.7,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:30Z",
      "evidence": [
        {
          "url": "https://www.wikidata.org/wiki/Special:EntityData/Q140045442.json",
          "capture": {
            "store": "ev",
            "sha256": "34cc1070812a051cf33559cf603dbbc559faa4f0585c4fb003c2d1325d68cca7"
          },
          "retrieved_at": "2026-11-17T09:17:30Z",
          "published_at": null,
          "quote": "Q140045442",
          "tier": "wiki",
          "locator": "jsonpath:$.entities.Q140045442.id",
          "media": null,
          "source_family": "wikidata",
          "method": "api",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Wikidata contributors",
            "license": "CC0-1.0",
            "basis": "license",
            "display": true,
            "export": true,
            "train": true,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_70693266f33d173fe97bfc4472347d87",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "website",
      "object": {
        "id": "domain:immunovant.com",
        "label": "immunovant.com",
        "type": "domain"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.9,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:20Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/",
          "capture": {
            "store": "ev",
            "sha256": "5e84077b437ea24fc8607a27c2e5dbb8dd5cd939b0195294ffe3a85e46bf59a4"
          },
          "retrieved_at": "2026-11-17T09:17:20Z",
          "published_at": null,
          "quote": "Immunovant, Inc.",
          "tier": "primary",
          "locator": null,
          "media": null,
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        },
        {
          "url": "https://www.wikidata.org/wiki/Special:EntityData/Q140045442.json",
          "capture": {
            "store": "ev",
            "sha256": "34cc1070812a051cf33559cf603dbbc559faa4f0585c4fb003c2d1325d68cca7"
          },
          "retrieved_at": "2026-11-17T09:17:30Z",
          "published_at": null,
          "quote": "https://www.immunovant.com",
          "tier": "wiki",
          "locator": "jsonpath:$.entities.Q140045442.claims.P856",
          "media": null,
          "source_family": "wikidata",
          "method": "api",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Wikidata contributors",
            "license": "CC0-1.0",
            "basis": "license",
            "display": true,
            "export": true,
            "train": true,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_d23637b4c9fb72e9b7be0207414948e2",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "identifier",
      "object": null,
      "value": {
        "scheme": "lei"
      },
      "datatype": "identifier",
      "polarity": "negative",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.9,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:27Z",
      "evidence": [
        {
          "url": "https://api.gleif.org/api/v1/lei-records?filter%5Bentity.legalName%5D=Immunovant%2C+Inc.",
          "capture": {
            "store": "ev",
            "sha256": "c128a29e8940e01bef2e87f9d6322c9cc151ba1776e94db63864e43e9e5c9224"
          },
          "retrieved_at": "2026-11-17T09:17:27Z",
          "published_at": null,
          "quote": null,
          "tier": "registry",
          "locator": "jsonpath:$.data.length",
          "media": null,
          "source_family": "gleif",
          "method": "api",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "GLEIF",
            "license": "CC0-1.0",
            "basis": "license",
            "display": true,
            "export": true,
            "train": true,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": {
        "kind": "not_found",
        "scope": "GLEIF lei-records API, legal-name filter 'Immunovant, Inc.'",
        "as_of": "2026-11-17"
      },
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_0b7da3078a05dfb98bf05d5e8a152545",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "identifier",
      "object": null,
      "value": {
        "scheme": "cik",
        "value": "0001764013"
      },
      "datatype": "identifier",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.95,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:27Z",
      "evidence": [
        {
          "url": "https://data.sec.gov/submissions/CIK0001764013.json",
          "capture": {
            "store": "ev",
            "sha256": "ff706aba65c7dd7550fda80d38b75f9125334fbed91d019d100488138a24c467"
          },
          "retrieved_at": "2026-11-17T09:17:27Z",
          "published_at": null,
          "quote": "0001764013",
          "tier": "registry",
          "locator": "jsonpath:$.cik",
          "media": null,
          "source_family": "sec-edgar",
          "method": "api",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "U.S. Securities and Exchange Commission (EDGAR)",
            "license": "public-record",
            "basis": "public_record",
            "display": true,
            "export": true,
            "train": true,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_3317e786bfc50d14409ecd5211bf515b",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "postal_address",
      "object": {
        "id": "addr:1000-park-forty-plaza-durham-nc-27713-us",
        "label": "1000 PARK FORTY PLAZA, DURHAM, NC 27713, US",
        "type": "postal_address"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.95,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:27Z",
      "evidence": [
        {
          "url": "https://data.sec.gov/submissions/CIK0001764013.json",
          "capture": {
            "store": "ev",
            "sha256": "ff706aba65c7dd7550fda80d38b75f9125334fbed91d019d100488138a24c467"
          },
          "retrieved_at": "2026-11-17T09:17:27Z",
          "published_at": null,
          "quote": "1000 PARK FORTY PLAZA",
          "tier": "registry",
          "locator": "jsonpath:$.addresses.business",
          "media": null,
          "source_family": "sec-edgar",
          "method": "api",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "U.S. Securities and Exchange Commission (EDGAR)",
            "license": "public-record",
            "basis": "public_record",
            "display": true,
            "export": true,
            "train": true,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_11cd8e3a334d4f9a549f6886d6ddf523",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "registered_in",
      "object": {
        "id": "delaware",
        "label": "Delaware",
        "type": "place"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.95,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:27Z",
      "evidence": [
        {
          "url": "https://data.sec.gov/submissions/CIK0001764013.json",
          "capture": {
            "store": "ev",
            "sha256": "ff706aba65c7dd7550fda80d38b75f9125334fbed91d019d100488138a24c467"
          },
          "retrieved_at": "2026-11-17T09:17:27Z",
          "published_at": null,
          "quote": "De",
          "tier": "registry",
          "locator": "jsonpath:$.stateOfIncorporation",
          "media": null,
          "source_family": "sec-edgar",
          "method": "api",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "U.S. Securities and Exchange Commission (EDGAR)",
            "license": "public-record",
            "basis": "public_record",
            "display": true,
            "export": true,
            "train": true,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_df0769334b66c75ef89c35b6de29735f",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "instance_of",
      "object": {
        "id": "public-company",
        "label": "public company",
        "type": "concept"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.95,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:27Z",
      "evidence": [
        {
          "url": "https://data.sec.gov/submissions/CIK0001764013.json",
          "capture": {
            "store": "ev",
            "sha256": "ff706aba65c7dd7550fda80d38b75f9125334fbed91d019d100488138a24c467"
          },
          "retrieved_at": "2026-11-17T09:17:27Z",
          "published_at": null,
          "quote": "IMVT",
          "tier": "registry",
          "locator": "jsonpath:$.exchanges",
          "media": null,
          "source_family": "sec-edgar",
          "method": "api",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "U.S. Securities and Exchange Commission (EDGAR)",
            "license": "public-record",
            "basis": "public_record",
            "display": true,
            "export": true,
            "train": true,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_f38bb5f295bd5a5fb063280bc88661f8",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "official_name",
      "object": null,
      "value": "Immunovant, Inc.",
      "datatype": "string",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.95,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:27Z",
      "evidence": [
        {
          "url": "https://data.sec.gov/submissions/CIK0001764013.json",
          "capture": {
            "store": "ev",
            "sha256": "ff706aba65c7dd7550fda80d38b75f9125334fbed91d019d100488138a24c467"
          },
          "retrieved_at": "2026-11-17T09:17:27Z",
          "published_at": null,
          "quote": "Immunovant, Inc.",
          "tier": "registry",
          "locator": "jsonpath:$.name",
          "media": null,
          "source_family": "sec-edgar",
          "method": "api",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "U.S. Securities and Exchange Commission (EDGAR)",
            "license": "public-record",
            "basis": "public_record",
            "display": true,
            "export": true,
            "train": true,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_98b473a4968824d0a7cdcbcb6fb0e2ce",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "has_feed",
      "object": {
        "id": "m_3806e6c8977db93721d71ca5c8224dd2",
        "label": "Immunovant, Inc. (IMVT) Press Releases",
        "type": "media:feed"
      },
      "value": null,
      "datatype": "media",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "current",
      "confidence": 0.9,
      "confidence_method": "direct_observation/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:25Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/investors/news-events/press-releases/rss",
          "capture": {
            "store": "media",
            "sha256": "21b764da4c6a66899b8d0221397128123cdffc8f9f5183220c90262d04a91ae4"
          },
          "retrieved_at": "2026-11-17T09:17:25Z",
          "published_at": null,
          "quote": null,
          "tier": "primary",
          "locator": null,
          "media": "m_3806e6c8977db93721d71ca5c8224dd2",
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [],
      "derivation": null,
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_a5ada1147c77c09b6ce5661acc5d2fc6",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "chief_executive",
      "object": {
        "id": "eric-venker",
        "label": "Eric Venker",
        "type": "person"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "inferred",
      "confidence": 0.5,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:23Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/about-us/our-leadership",
          "capture": {
            "store": "ev",
            "sha256": "a6ec4d4892590b0f6eb6472c4a2da972622e3f167c286dd1c4e58716272fa39c"
          },
          "retrieved_at": "2026-11-17T09:17:23Z",
          "published_at": null,
          "quote": "Eric Venker, MD, PharmD, is the Chief Executive Officer of Immunovant",
          "tier": "model",
          "locator": null,
          "media": null,
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [
        "o_b2c8d04fb723aa2ed6f488f5870b5d8b"
      ],
      "derivation": {
        "method": "model:deepseek-v4-flash",
        "version": "DeepSeek-V4-Flash-0731-MXFP4-MLX",
        "ran_at": "2026-11-17T10:03:12Z"
      },
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_57bb2b430a389d3cf21fd508fe21039f",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "board_member",
      "object": {
        "id": "frank-torti",
        "label": "Frank Torti",
        "type": "person"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "inferred",
      "confidence": 0.5,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:24Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/investors/corporate-governance",
          "capture": {
            "store": "ev",
            "sha256": "f63a61a70ec71b1d7990812948e39047e5a64f1a893b0d8c8d74a2e9e4fc24b9"
          },
          "retrieved_at": "2026-11-17T09:17:24Z",
          "published_at": null,
          "quote": "Frank Torti MD, MBA, is the Vant Chair and President at Roivant Sciences, Executive Chairman at Immunovant and Priovant",
          "tier": "model",
          "locator": null,
          "media": null,
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [
        "o_65deac71bc76b1ec24872443e96d3940"
      ],
      "derivation": {
        "method": "model:deepseek-v4-flash",
        "version": "DeepSeek-V4-Flash-0731-MXFP4-MLX",
        "ran_at": "2026-11-17T10:03:12Z"
      },
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_c6a89b10ce0d41a3c7a70123f5aba6b7",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "board_member",
      "object": {
        "id": "jake-bauer",
        "label": "Jake Bauer",
        "type": "person"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "inferred",
      "confidence": 0.5,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:24Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/investors/corporate-governance",
          "capture": {
            "store": "ev",
            "sha256": "f63a61a70ec71b1d7990812948e39047e5a64f1a893b0d8c8d74a2e9e4fc24b9"
          },
          "retrieved_at": "2026-11-17T09:17:24Z",
          "published_at": null,
          "quote": "Jake Bauer, MBA, has served as a member of our Board of Directors since April 2025",
          "tier": "model",
          "locator": null,
          "media": null,
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [
        "o_65deac71bc76b1ec24872443e96d3940"
      ],
      "derivation": {
        "method": "model:deepseek-v4-flash",
        "version": "DeepSeek-V4-Flash-0731-MXFP4-MLX",
        "ran_at": "2026-11-17T10:03:12Z"
      },
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_c4125f876c8280c36bc8302e1141dbad",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "board_member",
      "object": {
        "id": "andrew-fromkin",
        "label": "Andrew Fromkin",
        "type": "person"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "inferred",
      "confidence": 0.5,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:24Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/investors/corporate-governance",
          "capture": {
            "store": "ev",
            "sha256": "f63a61a70ec71b1d7990812948e39047e5a64f1a893b0d8c8d74a2e9e4fc24b9"
          },
          "retrieved_at": "2026-11-17T09:17:24Z",
          "published_at": null,
          "quote": "Andrew Fromkin has served as a member of our board of directors since October 2019",
          "tier": "model",
          "locator": null,
          "media": null,
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [
        "o_65deac71bc76b1ec24872443e96d3940"
      ],
      "derivation": {
        "method": "model:deepseek-v4-flash",
        "version": "DeepSeek-V4-Flash-0731-MXFP4-MLX",
        "ran_at": "2026-11-17T10:03:12Z"
      },
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_c2f894ed8a160e0c6dadf6431ff757dc",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "board_member",
      "object": {
        "id": "douglas-hughes",
        "label": "Douglas Hughes",
        "type": "person"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "inferred",
      "confidence": 0.5,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:24Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/investors/corporate-governance",
          "capture": {
            "store": "ev",
            "sha256": "f63a61a70ec71b1d7990812948e39047e5a64f1a893b0d8c8d74a2e9e4fc24b9"
          },
          "retrieved_at": "2026-11-17T09:17:24Z",
          "published_at": null,
          "quote": "Douglas Hughes, MBA has served as a member of our board of directors since October 2019",
          "tier": "model",
          "locator": null,
          "media": null,
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [
        "o_65deac71bc76b1ec24872443e96d3940"
      ],
      "derivation": {
        "method": "model:deepseek-v4-flash",
        "version": "DeepSeek-V4-Flash-0731-MXFP4-MLX",
        "ran_at": "2026-11-17T10:03:12Z"
      },
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_dfe4cb371f1aece8b67570fbea496806",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "board_member",
      "object": {
        "id": "atul-pande",
        "label": "Atul Pande",
        "type": "person"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "inferred",
      "confidence": 0.5,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:24Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/investors/corporate-governance",
          "capture": {
            "store": "ev",
            "sha256": "f63a61a70ec71b1d7990812948e39047e5a64f1a893b0d8c8d74a2e9e4fc24b9"
          },
          "retrieved_at": "2026-11-17T09:17:24Z",
          "published_at": null,
          "quote": "Atul Pande, MD, has served as a member of our board of directors since October 2019",
          "tier": "model",
          "locator": null,
          "media": null,
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [
        "o_65deac71bc76b1ec24872443e96d3940"
      ],
      "derivation": {
        "method": "model:deepseek-v4-flash",
        "version": "DeepSeek-V4-Flash-0731-MXFP4-MLX",
        "ran_at": "2026-11-17T10:03:12Z"
      },
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    },
    {
      "id": "k_ed64fa7510e941a87b2059b7afb369c8",
      "revision": 1,
      "subject": "immunovant-inc",
      "predicate": "board_member",
      "object": {
        "id": "robert-susman",
        "label": "Robert Susman",
        "type": "person"
      },
      "value": null,
      "datatype": "entity",
      "polarity": "positive",
      "epistemic": "asserted",
      "temporal": "unknown",
      "status": "inferred",
      "confidence": 0.5,
      "confidence_method": "tier_default/v1",
      "valid_from": null,
      "valid_to": null,
      "asserted_at": "2026-11-17T15:10:00Z",
      "retrieved_at": "2026-11-17T09:17:24Z",
      "evidence": [
        {
          "url": "https://www.immunovant.com/investors/corporate-governance",
          "capture": {
            "store": "ev",
            "sha256": "f63a61a70ec71b1d7990812948e39047e5a64f1a893b0d8c8d74a2e9e4fc24b9"
          },
          "retrieved_at": "2026-11-17T09:17:24Z",
          "published_at": null,
          "quote": "Robert Susman, MBA, has served as a member of our Board of Directors since April 2025",
          "tier": "model",
          "locator": null,
          "media": null,
          "source_family": "self",
          "method": "fetch",
          "extractor": {
            "name": "build_release",
            "version": "0.3.1"
          },
          "rights": {
            "holder": "Immunovant, Inc.",
            "license": "all-rights-reserved",
            "basis": "fair_use_excerpt",
            "display": true,
            "export": false,
            "train": false,
            "policy_version": "2026-10-20"
          }
        }
      ],
      "derived_from": [
        "o_65deac71bc76b1ec24872443e96d3940"
      ],
      "derivation": {
        "method": "model:deepseek-v4-flash",
        "version": "DeepSeek-V4-Flash-0731-MXFP4-MLX",
        "ran_at": "2026-11-17T10:03:12Z"
      },
      "qualifiers": {},
      "negation": null,
      "supersedes": null,
      "mirror_of": null
    }
  ],
  "media": [
    {
      "media": "m_3806e6c8977db93721d71ca5c8224dd2",
      "relation": "has_feed",
      "author": null,
      "evidence_for": [
        "k_98b473a4968824d0a7cdcbcb6fb0e2ce"
      ],
      "ingest": {
        "enabled": false,
        "interval_min": 360,
        "retention_items": 200
      },
      "object": {
        "id": "m_3806e6c8977db93721d71ca5c8224dd2",
        "kind": "feed",
        "format": "rss",
        "platform": "self",
        "url": "https://www.immunovant.com/investors/news-events/press-releases/rss",
        "provider_id": "3806e6c8977db937",
        "oembed": {
          "title": "Immunovant, Inc. (IMVT) Press Releases",
          "author_name": null,
          "author_url": null,
          "published": null,
          "thumbnail_url": null,
          "duration_s": null
        },
        "captures": [
          {
            "sha256": "21b764da4c6a66899b8d0221397128123cdffc8f9f5183220c90262d04a91ae4",
            "retrieved_at": "2026-11-17T09:17:25Z",
            "text": null,
            "transcript": null,
            "transcript_source": null,
            "lang": null,
            "rights": {
              "holder": "Immunovant, Inc.",
              "license": "all-rights-reserved",
              "basis": "fair_use_excerpt",
              "display": true,
              "export": false,
              "train": false,
              "policy_version": "2026-10-20"
            }
          }
        ],
        "availability": {
          "state": "live",
          "checked_at": "2026-11-17T09:17:25Z"
        }
      }
    }
  ],
  "version": 1,
  "created_at": "2026-11-17T15:10:00Z",
  "updated_at": "2026-11-17T15:10:00Z",
  "content_hash": "73ccbfe0eccd032d8e7f9b40275df396aac56bd7199a95b3315fb3e03b83b69d",
  "license": "ENTITI-ATTR-1.0"
}